P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis

<p>The role of p53 family proteins, both in the pathogenesis of chronic lymphoproliferative disorders, and in aspects of the growi ng interest in the<br />therapeutic potential of so-called small molecules capable of influencing the regulatory "relationship" of p53, MDM2, p21 a...

Full description

Bibliographic Details
Main Authors: P. M. Kondratovskiy, A. I. Dubikov, A. Yu. Doroshevskaya
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:http://oncohematology.abvpress.ru/index.php/ongm/article/view/92
_version_ 1797708814997258240
author P. M. Kondratovskiy
A. I. Dubikov
A. Yu. Doroshevskaya
author_facet P. M. Kondratovskiy
A. I. Dubikov
A. Yu. Doroshevskaya
author_sort P. M. Kondratovskiy
collection DOAJ
description <p>The role of p53 family proteins, both in the pathogenesis of chronic lymphoproliferative disorders, and in aspects of the growi ng interest in the<br />therapeutic potential of so-called small molecules capable of influencing the regulatory "relationship" of p53, MDM2, p21 and P UMA is currently actively debated. The article is an attempt to summarize the data on experimental tumor and mouse models and availablen ithe l iterature results of studies using human lymphoid tumors. Prognostic significance of p53 family proteins expression in lymphoproliferativ e diseases and possible therapeutic approaches using the features of the p53 relationship with regulators and effectors genes are considered.</p>
first_indexed 2024-03-12T06:28:11Z
format Article
id doaj.art-8ea1af6430b74ee882198fe31d67b7c4
institution Directory Open Access Journal
issn 1818-8346
language Russian
last_indexed 2024-03-12T06:28:11Z
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-8ea1af6430b74ee882198fe31d67b7c42023-09-03T01:48:39ZrusABV-pressОнкогематология1818-83462014-07-01636575107P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesisP. M. Kondratovskiy0A. I. Dubikov1A. Yu. Doroshevskaya2Vladivostok State Medical UniversityVladivostok State Medical UniversityVladivostok State Medical University<p>The role of p53 family proteins, both in the pathogenesis of chronic lymphoproliferative disorders, and in aspects of the growi ng interest in the<br />therapeutic potential of so-called small molecules capable of influencing the regulatory "relationship" of p53, MDM2, p21 and P UMA is currently actively debated. The article is an attempt to summarize the data on experimental tumor and mouse models and availablen ithe l iterature results of studies using human lymphoid tumors. Prognostic significance of p53 family proteins expression in lymphoproliferativ e diseases and possible therapeutic approaches using the features of the p53 relationship with regulators and effectors genes are considered.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/92chronic lymphoproliferative diseaseslymphomaschronic lymphocytic leukemiaapoptosisр53MDM2p21PUMA
spellingShingle P. M. Kondratovskiy
A. I. Dubikov
A. Yu. Doroshevskaya
P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
Онкогематология
chronic lymphoproliferative diseases
lymphomas
chronic lymphocytic leukemia
apoptosis
р53
MDM2
p21
PUMA
title P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
title_full P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
title_fullStr P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
title_full_unstemmed P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
title_short P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
title_sort p53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
topic chronic lymphoproliferative diseases
lymphomas
chronic lymphocytic leukemia
apoptosis
р53
MDM2
p21
PUMA
url http://oncohematology.abvpress.ru/index.php/ongm/article/view/92
work_keys_str_mv AT pmkondratovskiy p53pathwaychangesandtheirinfluenceonchroniclymphoproliferativediseasespathogenesis
AT aidubikov p53pathwaychangesandtheirinfluenceonchroniclymphoproliferativediseasespathogenesis
AT ayudoroshevskaya p53pathwaychangesandtheirinfluenceonchroniclymphoproliferativediseasespathogenesis